Pnv Ferrous Fumarate Docusate Folic Acid
Loading...Pnv Ferrous Fumarate Docusate Folic Acid Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
WARNINGS: Caution is recommended in patients with a history of bipolar illness. Mood elevation is possible in this population. Caution is also recommended in patients taking anticonvulsant medications as folate may interfere with anticonvulsant medication, and may lower seizure threshold. Furthermore, it has been reported that anticonvulsant medications interfere with folate metabolism, but the exact action is unclear; therefore caution is recommended with patients in this therapeutic group.
Folinic acid may enhance the toxicity of fluorouracil. Deaths from severe enterocolitis, diarrhea, and dehydration have been reported in elderly patients receiving weekly formyl-THF and fluorouracil. Concomitant granulocytopenia and fever were present in some but not all of the patients. The concomitant use of formyl-THF with trimethoprim-sulfamethoxazole for the acute treatment of Pneumocystis carinii pneumonia in patients with HIV infection was associated with increased rates of treatment failure and mortality in a placebo controlled study.13 Patients undergoing cancer treatment should consult their licensed medical practitioner for advice.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
PNV: Ferrous Fumarate/Docusate/Folic Acid (29 mg-25 mg-1 mg) is a prescription multivitamin/ multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. PNV: Ferrous Fumarate/Docusate/Folic Acid (29 mg-25 mg-1 mg) is also beneficial in improving the nutritional status of women prior to conception.
History
There is currently no drug history available for this drug.
Other Information
DESCRIPTION: PNV: Ferrous Fumarate/Docusate/Folic Acid (29 mg-25 mg-1 mg) is a prescription prenatal/postnatal multivitamin/ multimineral nutritional supplement. PNV: Ferrous Fumarate/Docusate/Folic Acid (29 mg-25 mg-1 mg) is an oblong shaped, blue colored tablet, imprinted with V254.
| Each tablet also contains the following ingredients for nutritional supplementation: | |
| Vitamin A (as beta carotene) | 1000 IU |
| Vitamin C (as ascorbic acid) | 100 mg |
| Vitamin D (as cholecalciferol) | 400 IU |
| Vitamin E (as dl-alpha tocopheryl acetate) | 30 IU |
| (Vitamin B1) (as thiamine mononitrate) | 3mg |
| Vitamin B2 (as riboflavin) | 3 mg |
| Niacin (as niacinamide) | 15 mg |
| Vitamin B6 (as pyridoxine HCI) | 20 mg |
| Folate (as folic acid) | 1 mg |
| Vitamin B12 (as cyanocobalamin) | 12 mcg |
| Pantothenic Acid (as calcium pantothenate) | 7 mg |
| Calcium (as calcium carbonate) | 200 mg |
| Iron (as ferrous fumarate) | 29 mg |
| Zinc (as zinc oxide) | 20 mg |
| Docusate Sodium (as docusate sodium) | 25 mg |
Sources
Pnv Ferrous Fumarate Docusate Folic Acid Manufacturers
-
Virtus Pharmaceuticals Llc
![Pnv Ferrous Fumarate Docusate Folic Acid Tablet [Virtus Pharmaceuticals Llc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Pnv Ferrous Fumarate Docusate Folic Acid | Virtus Pharmaceuticals Llc
One tablet daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.
Login To Your Free Account